Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$320.60+1.49 (+0.47%)
Close on Nov 18, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra net income
Net income is the profit left for shareholders after every expense, interest and tax.
Penumbra's net income for the twelve months ending Sep 30, 2026 was $157.02M, down 4.3% year over year. For fiscal 2025 it was $177.69M, up 1168.1% from the year before. Over ten years it grew 54.0% a year on average. The highest annual figure on record is $177.69M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.69M | +1168.1% |
| FY2024 | Dec 31, 2024 | $14.01M | -84.6% |
| FY2023 | Dec 31, 2023 | $90.95M | – |
| FY2022 | Dec 31, 2022 | -$2.00M | -137.9% |
| FY2021 | Dec 31, 2021 | $5.28M | – |
| FY2020 | Dec 31, 2020 | -$15.70M | -132.4% |
| FY2019 | Dec 31, 2019 | $48.46M | +634.1% |
| FY2018 | Dec 31, 2018 | $6.60M | +41.7% |
| FY2017 | Dec 31, 2017 | $4.66M | -68.6% |
| FY2016 | Dec 31, 2016 | $14.81M | +526.4% |
| FY2015 | Dec 31, 2015 | $2.37M | +5.3% |
| FY2014 | Dec 31, 2014 | $2.25M | -45.2% |
| FY2013 | Dec 31, 2013 | $4.10M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $42.28M | -7.8% |
| Q2 FY2026 | Jun 30, 2026 | $34.81M | -23.1% |
| Q1 FY2026 | Mar 31, 2026 | $32.58M | -16.9% |
| Q4 FY2025 | Dec 31, 2025 | $47.34M | +40.6% |
| Q3 FY2025 | Sep 30, 2025 | $45.85M | +55.3% |
| Q2 FY2025 | Jun 30, 2025 | $45.27M | – |
| Q1 FY2025 | Mar 31, 2025 | $39.22M | +256.5% |
| Q4 FY2024 | Dec 31, 2024 | $33.68M | -37.9% |
| Q3 FY2024 | Sep 30, 2024 | $29.53M | +220.5% |
| Q2 FY2024 | Jun 30, 2024 | -$60.20M | -417.5% |
| Q1 FY2024 | Mar 31, 2024 | $11.00M | +28.5% |
| Q4 FY2023 | Dec 31, 2023 | $54.22M | +1298.5% |
| Q3 FY2023 | Sep 30, 2023 | $9.21M | – |
| Q2 FY2023 | Jun 30, 2023 | $18.96M | – |
| Q1 FY2023 | Mar 31, 2023 | $8.56M | +10738.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.27M | -125.7% |
| Q2 FY2022 | Jun 30, 2022 | -$3.69M | -139.9% |
| Q1 FY2022 | Mar 31, 2022 | $79.00K | -99.3% |
| Q4 FY2021 | Dec 31, 2021 | -$24.63M | -775.2% |
| Q3 FY2021 | Sep 30, 2021 | $8.85M | – |
| Q2 FY2021 | Jun 30, 2021 | $9.23M | – |
| Q1 FY2021 | Mar 31, 2021 | $11.84M | +730.6% |
| Q4 FY2020 | Dec 31, 2020 | $3.65M | -62.3% |
| Q3 FY2020 | Sep 30, 2020 | -$8.82M | -176.8% |
| Q2 FY2020 | Jun 30, 2020 | -$11.96M | -172.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.43M | -86.7% |
| Q4 FY2019 | Dec 31, 2019 | $9.69M | +45.5% |
| Q3 FY2019 | Sep 30, 2019 | $11.48M | – |
| Q2 FY2019 | Jun 30, 2019 | $16.59M | +24.0% |
| Q1 FY2019 | Mar 31, 2019 | $10.70M | +94.8% |
| Q4 FY2018 | Dec 31, 2018 | $6.66M | -26.7% |
| Q3 FY2018 | Sep 30, 2018 | -$18.93M | -8053.8% |
| Q2 FY2018 | Jun 30, 2018 | $13.38M | – |
| Q1 FY2018 | Mar 31, 2018 | $5.49M | – |
| Q4 FY2017 | Dec 31, 2017 | $9.08M | – |
| Q3 FY2017 | Sep 30, 2017 | $238.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.56M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.11M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.40M | – |
See a number that looks wrong?